Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000508351 | SCV000600277 | uncertain significance | not specified | 2017-01-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001051454 | SCV001215608 | benign | Hereditary breast ovarian cancer syndrome | 2023-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431463 | SCV002731415 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-01-11 | criteria provided, single submitter | clinical testing | The p.S725G variant (also known as c.2173A>G), located in coding exon 9 of the BRCA1 gene, results from an A to G substitution at nucleotide position 2173. The serine at codon 725 is replaced by glycine, an amino acid with similar properties. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
University of Washington Department of Laboratory Medicine, |
RCV002431463 | SCV003849443 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |